Literature DB >> 24664485

Management of localized esophageal cancer in the older patient.

Elizabeth Won1, David H Ilson.   

Abstract

Most patients with gastroesophageal cancers are older than 65 years of age. The management of older patients poses challenges because they have multiple comorbidities and physiological changes associated with aging. Furthermore, data are limited on tolerance of cancer therapy and the use of combined-modality treatments in this patient population to guide their treatment. In this article, we focus on the management of older patients with localized esophageal cancer, highlighting the role of comprehensive geriatric assessment to identify and better tailor treatment approaches in this patient population. We review the literature and discuss the role of surgical resection and potential complications specific to an older patient. We review the rationale of combined-modality treatment and the potential benefits of a chemoradiotherapy-based approach in this patient population.

Entities:  

Keywords:  Chemoradiotherapy; Elderly; Esophageal cancer; Geriatric oncology

Mesh:

Year:  2014        PMID: 24664485      PMCID: PMC3983810          DOI: 10.1634/theoncologist.2013-0178

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  56 in total

1.  Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.

Authors:  Alberto Ruol; Giuseppe Portale; Carlo Castoro; Stefano Merigliano; Matteo Cagol; Francesco Cavallin; Vanna Chiarion Sileni; Luigi Corti; Sabrina Rampado; Mario Costantini; Ermanno Ancona
Journal:  Ann Surg Oncol       Date:  2007-08-23       Impact factor: 5.344

2.  Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study.

Authors:  Stephanie Servagi-Vernat; Mathieu Bosset; Gilles Crehange; Jöelle Buffet-Miny; Marc Puyraveau; Philippe Maingon; Mariette Mercier; Jean François Bosset
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  Outcomes in octogenarians undergoing high-risk cancer operation: a national study.

Authors:  Emily Finlayson; Zhaohui Fan; John D Birkmeyer
Journal:  J Am Coll Surg       Date:  2007-10-01       Impact factor: 6.113

4.  Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus.

Authors:  Masaru Morita; Akinori Egashira; Rintaro Yoshida; Keisuke Ikeda; Kippei Ohgaki; Kotaro Shibahara; Eiji Oki; Noriaki Sadanaga; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

5.  Redefining geriatric preoperative assessment using frailty, disability and co-morbidity.

Authors:  Thomas N Robinson; Ben Eiseman; Jeffrey I Wallace; Skotti D Church; Kim K McFann; Shirley M Pfister; Terra J Sharp; Marc Moss
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969

6.  Geriatric co-management of proximal femur fractures: total quality management and protocol-driven care result in better outcomes for a frail patient population.

Authors:  Susan M Friedman; Daniel A Mendelson; Stephen L Kates; Robert M McCann
Journal:  J Am Geriatr Soc       Date:  2008-05-22       Impact factor: 5.562

7.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.

Authors:  O Pech; A Behrens; A May; L Nachbar; L Gossner; T Rabenstein; H Manner; E Guenter; J Huijsmans; M Vieth; M Stolte; C Ell
Journal:  Gut       Date:  2008-05-06       Impact factor: 23.059

8.  Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model.

Authors:  Jin Ra; E Carter Paulson; John Kucharczuk; Katrina Armstrong; Christopher Wirtalla; Rachel Rapaport-Kelz; Larry R Kaiser; Francis R Spitz
Journal:  Ann Surg Oncol       Date:  2008-04-01       Impact factor: 5.344

9.  Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study.

Authors:  R A Audisio; D Pope; H S J Ramesh; R Gennari; B L van Leeuwen; C West; G Corsini; M Maffezzini; H J Hoekstra; D Mobarak; F Bozzetti; M Colledan; H Wildiers; A Stotter; A Capewell; E Marshall
Journal:  Crit Rev Oncol Hematol       Date:  2007-12-21       Impact factor: 6.312

10.  Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.

Authors:  D Tougeron; F Di Fiore; S Thureau; N Berbera; I Iwanicki-Caron; H Hamidou; B Paillot; P Michel
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

View more
  13 in total

1.  Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation.

Authors:  Rishi Jain; Jia-Llon Yee; Talha Shaikh; Cherry Au; Elizabeth Handorf; Joshua E Meyer; Efrat Dotan
Journal:  J Geriatr Oncol       Date:  2019-06-28       Impact factor: 3.599

2.  Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trial.

Authors:  Ryan D Nipp; Carolyn L Qian; Helen P Knight; Cristina R Ferrone; Hiroko Kunitake; Carlos Fernandez-Del Castillo; Michael Lanuti; Motaz Qadan; Rocco Ricciardi; Keith D Lillemoe; Brandon Temel; Ardeshir Z Hashmi; Erin Scott; Erin Stevens; Grant R Williams; Zhi Ven Fong; Terrence A O'Malley; Esteban Franco-Garcia; Nora K Horick; Vicki A Jackson; Joseph A Greer; Areej El-Jawahri; Jennifer S Temel
Journal:  J Geriatr Oncol       Date:  2022-01-21       Impact factor: 3.929

3.  Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review.

Authors:  Elham Rahimy; Amanda Koong; Diego Toesca; Maya N White; Neil Panjwani; George Fisher; Daniel Chang; Erqi Pollom
Journal:  Adv Radiat Oncol       Date:  2020-05-21

4.  Health related quality of life after oesophagectomy: elderly patients refer similar eating and swallowing difficulties than younger patients.

Authors:  Francesco Cavallin; Eleonora Pinto; Luca M Saadeh; Rita Alfieri; Matteo Cagol; Carlo Castoro; Marco Scarpa
Journal:  BMC Cancer       Date:  2015-09-21       Impact factor: 4.430

5.  Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE).

Authors:  Stéphanie Servagi-Vernat; Gilles Créhange; Franck Bonnetain; Cécile Mertens; Etienne Brain; Jean François Bosset
Journal:  BMC Cancer       Date:  2017-07-13       Impact factor: 4.430

6.  Tumor Compactness based on CT to predict prognosis after multimodal treatment for esophageal squamous cell carcinoma.

Authors:  Qifeng Wang; Bangrong Cao; Junqiang Chen; Chen Li; Lijun Tan; Wencheng Zhang; Jiahua Lv; Xiqing Li; Miyong Xiao; Yu Lin; Jinyi Lang; Tao Li; Zefen Xiao
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

7.  Comparative study of esophagectomy, endoscopic therapy, and radiotherapy for cT1N0M0 esophageal cancer in elderly patients: A SEER database analysis.

Authors:  Jianjun Qin; Yinjie Peng; Weipeng Chen; Haibo Ma; Yan Zheng; Yin Li; Jun Wang
Journal:  Thorac Cancer       Date:  2019-06-14       Impact factor: 3.500

8.  Survival benefit of perioperative chemotherapy for T1-3N0M0 stage esophageal cancer: a SEER database analysis.

Authors:  Yue Shao; Dan Chen; Liu Ye; Xin-Mei Wang; Qing-Chen Wu; Cheng Zhang
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

9.  Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database.

Authors:  Xiaojie Xia; Qing Gao; Xiaolin Ge; Zeyuan Liu; Xiaoke Di; Xinchen Sun; Yan Yang
Journal:  Front Oncol       Date:  2021-09-07       Impact factor: 6.244

10.  Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.

Authors:  Lina Zhao; Yongchun Zhou; Haitao Pan; Yutian Yin; Guangjin Chai; Yunfeng Mu; Feng Xiao; Steven H Lin; Mei Shi
Journal:  J Cancer       Date:  2017-09-15       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.